(Q39399033)

11 September 2017

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma (English)

1 reference

11 September 2017

12

Fumihiro Tanaka

1 reference

11 September 2017

Yoshie Yoshikawa

1

1 reference

11 September 2017

Ayuko Sato

2

1 reference

11 September 2017

Tohru Tsujimura

3

1 reference

11 September 2017

Mitsuru Emi

4

1 reference

11 September 2017

Tomonori Morinaga

5

1 reference

11 September 2017

Kazuya Fukuoka

6

1 reference

11 September 2017

Shusai Yamada

7

1 reference

11 September 2017

Aki Murakami

8

1 reference

11 September 2017

Nobuyuki Kondo

9

1 reference

11 September 2017

Seiji Matsumoto

10

1 reference

11 September 2017

Yoshitomo Okumura

11

1 reference

11 September 2017

Seiki Hasegawa

13

1 reference

11 September 2017

Takashi Nakano

14

1 reference

11 September 2017

Tomoko Hashimoto-Tamaoki

15

1 reference

11 September 2017

21 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

103

1 reference

11 September 2017

868-874

1 reference

11 September 2017

5

1 reference

Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Multimodality approach in management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Germline mutations in BAP1 predispose to melanocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Germline BAP1 mutations predispose to malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02223.X

Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells

21 January 2018

1 reference

12 December 2020

Latency of asbestos disease among insulation workers in the United States and Canada

1 reference

12 December 2020

Codeletion of p15 and p16 in primary malignant mesothelioma

1 reference

12 December 2020

Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas

1 reference

12 December 2020

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

12 December 2020

Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02223.X

Identifiers

DOI

1 reference

11 September 2017

1 reference